INS and type 1 diabetes mellitus: Notably, adjunctive exenatide therapy has been shown to decline postprandial hyperglycemia in adolescents with T1DM even in the presence of reduced insulin dose; thus, exenatide bears significant therapeutic potential for adjunctive treatment of T1DM (Raman et al. 2010).